Compare Immunovant Inc. Common Stock (IMVT) vs Ingersoll Rand (IR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Ingersoll Rand — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Ingersoll Rand trades at $78.16 (market cap $29.97B). The key difference: Ingersoll Rand is far larger — about 4.5× Immunovant Inc. Common Stock's market cap, and Ingersoll Rand pays a 0.1% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Ingersoll Rand for 7 Days on average.
| IMVT | IR | |
|---|---|---|
Market Cap | $6.62B | $29.97B |
Volume | 1,131,364 | 4,688,805 |
Sector | Health | Industrials |
52-Week High | $44.96 | $98.76 |
52-Week Low | $17.03 | $68.54 |
Typical Hold Time | 0 Days | 7 Days |
Enterprise Value | $5.72B | $33.63B |
Dividend Yield | — | 0.1% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Ingersoll Rand
Ingersoll Rand develops industrial technologies for creating and managing flow, pressure, and motion. Its portfolio includes compressors, pumps, vacuum systems, and other equipment used across industrial markets.
Read more on IR →
